MedTrace Logo

Genetic Aortic Diseases and Cardiovascular Complications. An Observational Survey of Risk Factors.

NCT07391293 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2026-02-05

No results posted yet for this study

Summary

The aim of this observational study is to define the behavioural and cardiovascular risk factor profiles of patients with genetic aortopathies. The main questions it aims to answer are:

* How do the interconnections between lifestyle, stress, psychological condition, perception of illness, and state of health influence each other in this population?
* Beyond traditional risk factors, additional emerging factors should be considered, including pregnancy-related complications, sedentary lifestyle, early menopause and depression. The interplay between eating disorders, lifestyle factors and autoimmune or inflammatory bowel diseases remains poorly understood.

Conditions

  • Thoracic Aortic Aneurysm (TAA)

Interventions

OTHER

Journey to diagnosis

Questions relating to the course and experience/history of the disease from the onset of symptoms to confirmation of diagnosis; accessibility to referral facilities for treatment and follow-up.

OTHER

Quality of life, functional health and well-being

Qestionnaires

OTHER

Awareness and self-esteem, acceptance of the condition

questionnaire related to the quality of life and self-care

OTHER

psychological and physical well-being

questionnaire to describe psychological and physical well-being.

Sponsors & Collaborators

  • IRCCS Policlinico S. Donato

    lead OTHER

Eligibility

Min Age
14 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-06
Primary Completion
2026-12-31
Completion
2027-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07391293 on ClinicalTrials.gov